Samil Pharm (000520.KS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7000520007
Samil Pharm financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 219.70 bn KRW | 210.25 bn KRW |
| Gross profit | 80.91 bn KRW | 77.12 bn KRW |
| Operating income | 113.04 m KRW | -22.21 bn KRW |
| EBIT | 1.44 bn KRW | -28.39 bn KRW |
| Net income | -5.63 bn KRW | -34.66 bn KRW |
| Diluted EPS – continuing operations | -265.14 KRW | -1,632.80 KRW |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Samil Pharm
Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.
More stocks
- Sam Young Chem (003720.KS)
- iFamily Co. Ltd. (114840.KQ)
- SaraminHR Co.Ltd (143240.KQ)
- Sound Financial Bancorp, Inc. (SFBC)
- Seoyon Co Ltd (007860.KS)
- Davicom Semiconductor Inc (3094.TW)
- Shiny Brands Group Co., Ltd. (6703.TWO)
- Glintt (GLINT.LS)
- Global Lighting Technologies Inc (4935.TW)
- CUCKOO International (MAL) Berhad (5336.KL)
- Hwaseung Enterprise Co Ltd (241590.KS)
- Ambra SA (AMB.WA)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.